Change in antibody-dependent cellular cytotoxicity between baseline and day 15, day 30, and day 45 for cohort 1 and 2 versus cohort 3. Change in antibody-dependent.

Slides:

Advertisements

Similar presentations

Supplemental Figure 1 A B Supplemental Figure 1. F ‑ IgG and IL-12 mediated NK cell lysis is dependent on the folate receptor availability and does not.

Advertisements

Generation of new peptide-Fc fusion proteins that mediate antibody-dependent cellular cytotoxicity against different types of cancer cells Mouldy Sioud,

NEO PATIENTS FcγRIIIA V/V carriers FcγRIIIA F carriers

Melanoma donor (MD) NK cells are functionally impaired/exhausted.

Combined RAF and EGFR inhibition leads to improved in vivo efficacy in BRAF-mutant colorectal cancer. Combined RAF and EGFR inhibition leads to improved.

A: Box plot comparing the average changes in HbA1c between surgery and medical/lifestyle treatments in the first reports of the 11 RCTs published to date.

Ex vivo induction of multiple myeloma–specific cytotoxic T lymphocytes

Rapid generation of combined CMV-specific CD4+ and CD8+ T-cell lines for adoptive transfer into recipients of allogeneic stem cell transplants by Georg.

Volume 138, Issue 5, Pages e2 (May 2010)

AZD7762 abrogated the G2 checkpoint in a novel hollow fiber assay.

FLT3 ligand administration after hematopoietic cell transplantation increases circulating dendritic cell precursors that can be activated by CpG oligodeoxynucleotides.

Fig. 8. Gene and protein changes in ALK-dependent STING pathways in human sepsis. Gene and protein changes in ALK-dependent STING pathways in human sepsis.

Generation of new peptide-Fc fusion proteins that mediate antibody-dependent cellular cytotoxicity against different types of cancer cells Mouldy Sioud,

Bromohydrin pyrophosphate enhances antibody-dependent cell-mediated cytotoxicity induced by therapeutic antibodies by Julie Gertner-Dardenne, Cecile Bonnafous,

The absence of ADCC by nivolumab in vitro.

Circulating Natural Killer Lymphocytes Are Potential Cytotoxic Effectors Against Autologous Malignant Cells in Sezary Syndrome Patients Jean-David Bouaziz,

Box-And-Whisker Plots

Fig. 6 Innate and adaptive immunity, but not ADCC, contributes to M7824 antitumor activity. Innate and adaptive immunity, but not ADCC, contributes to.

Effects of daratumumab on natural killer cells and impact on clinical outcomes in relapsed or refractory multiple myeloma by Tineke Casneuf, Xu Steven.

Figure 3 Flu immunization–induced changes in the proportions and absolute numbers of RORγt-expressing CD4+ and CD8+ T cells Flu immunization–induced changes.

Figure 1 Flu immunization–induced changes in the proportions and absolute numbers of T cells and their relevant subpopulations Flu immunization–induced.

Regorafenib inhibits angiogenesis and induces apoptosis.

PD-1 blockade enhances T-cell function.

Interleukin 15 is a potent stimulant of intraepithelial lymphocytes

Anifrolumab does not elicit antibody-dependent cell-mediated cytotoxicity (ADCC) or complement-dependent cytotoxicity (CDC) activity. Anifrolumab does.

Box plot of acquisition times across the various study cohorts.

IL-6 signaling affects response to erlotinib in head and neck (HNSCC) cells. IL-6 signaling affects response to erlotinib in head and neck (HNSCC) cells.

A, IC50 dose–response curves of SYD985, T-DM1, and ADC isotype control in all USC cell lines tested in vitro (i.e., HER2 3+ cell lines, P =

Molecular Therapy - Oncolytics

CD16 uses additional pathways for killing.

Assessing the effect of TNF-α and TRAIL on A2-PPI15–24 CD8 T-cell cytotoxicity. Assessing the effect of TNF-α and TRAIL on A2-PPI15–24 CD8 T-cell cytotoxicity.

A, rate of proliferation of PC3 prostate cancer cells is greatly reduced by treatment with oligomers containing CpG motifs, as assessed by (a) soft agar.

Cytotoxic activity of HER2-lytic hybrid peptide.

Diagnostic plots of the TGI PKPD model fitted to the A677 TGI data.

T-VISA is robust in ovarian cancer cell lines.

Evaluation of top candidate clones for selective killing in bispecific antibody format. Evaluation of top candidate clones for selective killing in bispecific.

Effect of HA on hematopoietic recovery in tumor-bearing mice.

A, chemical structures of PRIMA-1 and PRIMA-1Met.

In vitro invasion assays were done in the Chemicon invasion chamber containing extracellular matrix. In vitro invasion assays were done in the Chemicon.

Anti-CD20 CAR mRNA enhances exPBNK in vitro cytolytic activity against CD20+ B-NHL cells and rituximab-resistant cells. exPBNK were electroporated in the.

CCG regulates cellular localization and blocks target gene expression of MRTF. A, SK-Mel-147 cells were cotransfected with RhoC and the SRE.L reporter.

Effects of WDL on in vitro invasion and soft agar colony formation by LNCaP cells. Effects of WDL on in vitro invasion and soft agar colony formation by.

Consequences of ICAM-1 expression modulation on the lysis of T1 and G1 cells. Consequences of ICAM-1 expression modulation on the lysis of T1 and G1 cells.

PD-1 inhibition stimulates the proliferation and cytokine secretion of exhausted/senescent CD8+ T cells in vitro. PD-1 inhibition stimulates the proliferation.

Drug sensitivities of IGROV1 cells to AGF94 and PMX at leucovorin (LCV) concentrations of 2 and 25 nmol/L. Drug sensitivities of IGROV1 cells to AGF94.

IL-13Rα2 promotes cell survival and proliferation.

The differential susceptibility to CTL-induced lysis does not involve Melan-A antigen expression. The differential susceptibility to CTL-induced lysis.

Effect of IL24 on phosphorylation of eIF2α and proliferation in cancer cells. Effect of IL24 on phosphorylation of eIF2α and proliferation in cancer cells.

LY induces replication stress and depletes the pool of available RPA2 for binding to DNA. HeLa cells were treated with 0.4% DMSO, 100 nmol/L LY

Colony formation of K-562 cells after 24 h (upper panel) or 48 h (lower panel) exposure to ErPC3 (20 μm) and ASO-bcr (10 μm), respectively. Colony formation.

Tumor and serum levels of murine IL-12.

ALT-803 stimulates proliferation and activation of human NK cells and T cells in vitro. ALT-803 stimulates proliferation and activation of human NK cells.

Cytotoxic activity of CD8+ T-cells stimulated with SSX2-derived p

Binding and antiproliferative effects of ANG4043 and anti-HER2 mAbs on tumor cells. Binding and antiproliferative effects of ANG4043 and anti-HER2 mAbs.

IL8 and TNFα are required for neutrophil-induced UMSCC47 increase in invasion. IL8 and TNFα are required for neutrophil-induced UMSCC47 increase in invasion.

Canonical but not adaptive NK-cell function is suppressed by Tregs.

Carcinoma cell–secreted IL-1 induces PGE2 production in MSCs

Mite allergen–specific IgE is detectable in bronchial secretions of patients with nonatopic asthma and correlates with mucosal expression of periostin

Patient Tregs express normal levels of suppression.

The best response for target lesions per patient for patients with target lesions assessed at baseline and at least 1 follow-up. The best response for.

Dgk inhibitors enhance the cytotoxic capacity of impaired human mesoCAR-transduced T cells. Dgk inhibitors enhance the cytotoxic capacity of impaired human.

Inhibition of CD20 mRNA expression by ibrutinib correlates with reduced NF-κB activity. Inhibition of CD20 mRNA expression by ibrutinib correlates with.

CpG oligodeoxynucleotide (CpG ODN)–induced activation of different types of primary malignant B cells. CpG oligodeoxynucleotide (CpG ODN)–induced activation.

Anti–TGF-β1 antibody neutralizes APB-mediated immune suppression.

Target-dependent T cell–mediated cytotoxicity of HER2-TDB.

Activation status of NK cells is associated with therapeutic effects of TKIs. PBMCs from CML patients were cocultured with HLA class I–deficient K562 cells.

Cell counts of immune infiltrate and expression of galectin-1 and galectin-3 in the short-, medium-, and long-term survival cohorts. Cell counts of immune.

Effects of NMT siRNAs on MARCKS and c-Src.

Loss of NQO1 expression inhibits invasion of NSCLC

Design and operation of p.DOM-epitope vaccines.

Presentation transcript:

Change in antibody-dependent cellular cytotoxicity between baseline and day 15, day 30, and day 45 for cohort 1 and 2 versus cohort 3. Change in antibody-dependent cellular cytotoxicity between baseline and day 15, day 30, and day 45 for cohort 1 and 2 versus cohort 3. Purified PBMCs from patients enrolled in the trial were incubated overnight with medium supplemented with 10 ng/mL IL12. The lytic activity of patient PBMCs cells was assessed in a standard 4-hour chromium release assay using cetuximab-coated HT29 human colorectal cancer cells. The change in mean percent lysis at 25:1 effector:target ratio for 10 patients enrolled in cohort 1 and 2 and the remaining 12 patients enrolled in cohort 3 between baseline and day 15, baseline and day 30, and baseline and day 45 is shown in box plots, represented as baseline ADCC values subtracted from ADCC values at later time points. The box plots represent the median and interquartile range, with I bars showing the range for each group. *, P = 0.01. Erin M. Bertino et al. Mol Cancer Ther 2016;15:2244-2250 ©2016 by American Association for Cancer Research